X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
2-arachidonoylglycerol (599) 599
animals (405) 405
index medicus (400) 400
endocannabinoids (322) 322
anandamide (319) 319
humans (266) 266
neurosciences (195) 195
mice (192) 192
male (189) 189
pharmacology & pharmacy (175) 175
arachidonic acids - metabolism (162) 162
monoacylglycerol lipase (154) 154
biochemistry & molecular biology (152) 152
rats (151) 151
brain (146) 146
glycerides - metabolism (146) 146
acid amide hydrolase (141) 141
lipids (138) 138
endocannabinoid (130) 130
lipase (126) 126
endocannabinoid system (117) 117
endocannabinoids - metabolism (111) 111
arachidonic acids - pharmacology (107) 107
cannabinoid receptor (102) 102
enzyme inhibitors - pharmacology (98) 98
article (94) 94
cannabinoid receptors (90) 90
monoacylglycerol lipases - antagonists & inhibitors (90) 90
monoacylglycerol lipases - metabolism (86) 86
cannabinoid receptor modulators - metabolism (85) 85
physiological aspects (85) 85
enzymes (84) 84
hydrolysis (84) 84
glycerides - pharmacology (83) 83
cannabinoid (82) 82
cb1 receptor (79) 79
cannabinoids (75) 75
fatty acids (75) 75
activation (73) 73
analysis (71) 71
cell biology (71) 71
receptor, cannabinoid, cb1 - metabolism (71) 71
system (71) 71
fatty acid amide hydrolase (70) 70
female (69) 69
rat-brain (68) 68
mice, inbred c57bl (67) 67
endocannabinoid 2-arachidonoylglycerol (66) 66
monoglyceride lipase (61) 61
2-arachidonylglycerol (60) 60
nervous system (60) 60
research (60) 60
neurons (59) 59
cells (55) 55
expression (54) 54
molecular characterization (54) 54
rats, sprague-dawley (54) 54
endogenous cannabinoids (52) 52
inhibition (52) 52
amidohydrolases - metabolism (51) 51
cb1 (51) 51
piperidines - pharmacology (51) 51
brain - metabolism (50) 50
dose-response relationship, drug (50) 50
inflammation (50) 50
polyunsaturated alkamides (50) 50
2‐arachidonoylglycerol (48) 48
receptors (48) 48
mice, knockout (47) 47
rats, wistar (47) 47
amidohydrolases - antagonists & inhibitors (46) 46
signal transduction (46) 46
cannabinoid receptor-ligand (45) 45
chemistry, medicinal (45) 45
2-ag (44) 44
identification (44) 44
polyunsaturated alkamides - metabolism (44) 44
disease models, animal (42) 42
glycerol (42) 42
cells, cultured (41) 41
ligands (40) 40
psychiatry (40) 40
receptor (40) 40
rodents (40) 40
biophysics (39) 39
biosynthesis (39) 39
receptor, cannabinoid, cb2 - metabolism (39) 39
endocannabinoids - pharmacology (38) 38
lipoprotein lipase - metabolism (38) 38
metabolism (38) 38
pharmacology (38) 38
signal transduction - drug effects (38) 38
arachidonic acid (37) 37
in-vivo (37) 37
receptors, cannabinoid - metabolism (37) 37
mass spectrometry (35) 35
neurology (35) 35
signal transduction - physiology (35) 35
biomedicine (34) 34
carbamates - pharmacology (34) 34
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Neuroscience, ISSN 1097-6256, 08/2010, Volume 13, Issue 8, pp. 951 - 957
Journal Article
Cell Death and Disease, ISSN 2041-4889, 10/2013, Volume 4, Issue 10, pp. e862 - e862
The cannabinoid CB2 receptor, which is activated by the endocannabinoid 2-arachidonoyl-glycerol (2-AG), protects striatal neurons from apoptotic death caused... 
Neuroprotection | Malonate | Endocannabinoids; CB1 and CB2 receptors; diacyl-glycerol lipase; monoacyl-glycerol lipase; cyclooxygenase-2; Huntington's disease | CB1 and CB2 receptors | COX-2 | ALZHEIMERS-DISEASE | BASAL GANGLIA | diacyl-glycerol lipase | cyclooxygenase-2 | NEURODEGENERATION | MODEL | Huntington's disease | malonate | CELL BIOLOGY | CANNABINOID RECEPTORS | ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL | TRAUMATIC BRAIN-INJURY | neuroprotection | IN-VIVO | endocannabinoids | monoacyl-glycerol lipase | HUNTINGTONS-DISEASE | L-Lactate Dehydrogenase - metabolism | Brain-Derived Neurotrophic Factor - genetics | Neurons - pathology | Lipoprotein Lipase - antagonists & inhibitors | Monoacylglycerol Lipases - antagonists & inhibitors | gamma-Aminobutyric Acid - metabolism | Male | PPAR gamma - metabolism | RNA, Messenger - metabolism | Arachidonic Acids - biosynthesis | Monoacylglycerol Lipases - metabolism | Cyclooxygenase 2 - genetics | Cytoprotection - drug effects | Inflammation Mediators - metabolism | Endocannabinoids - biosynthesis | Brain-Derived Neurotrophic Factor - metabolism | Cell Death - drug effects | Neurons - drug effects | Lipoprotein Lipase - metabolism | PPAR delta - genetics | PPAR gamma - genetics | Neostriatum - pathology | Nerve Degeneration - enzymology | RNA, Messenger - genetics | Rats | Glycerides - biosynthesis | Rats, Sprague-Dawley | Nerve Degeneration - pathology | Dinoprostone - metabolism | Malonates - toxicity | Animals | Nitric Oxide Synthase Type II - genetics | Models, Biological | Neurons - enzymology | Cyclooxygenase 2 - metabolism | Dinoprostone - analogs & derivatives | PPAR delta - metabolism | Nitric Oxide Synthase Type II - metabolism | Index Medicus | Original
Journal Article
JOURNAL OF CELLULAR BIOCHEMISTRY, ISSN 0730-2312, 01/2018, Volume 119, Issue 1, pp. 876 - 884
Journal Article
Psychopharmacology, ISSN 0033-3158, 8/2015, Volume 232, Issue 15, pp. 2811 - 2825
Journal Article
Chemical Society Reviews, ISSN 0306-0012, 9/2014, Volume 43, Issue 19, pp. 6859 - 6869
Journal Article
Chemical Society Reviews, ISSN 0306-0012, 09/2014, Volume 43, Issue 19, pp. 6859 - 6869
The endocannabinoid system, most popularly known as the target of the psychoactive component of marijuana, Delta super(9)-tetrahydrocannabinol (THC), is a... 
Networks | Enzymes | Inhibitors | Eyes | Derivatives | Lipase | Metabolism | Diseases
Journal Article
Journal Article
Experimental Neurology, ISSN 0014-4886, 11/2015, Volume 273, pp. 36 - 44
Parkinson's disease (PD) is a common chronic neurodegenerative disorder, usually of idiopathic origin. Symptoms including tremor, bradykinesia, rigidity and... 
Neuroprotection | Parkinson's disease | MPTP | Endocannabinoids | CB1 CANNABINOID RECEPTORS | TOXICITY IN-VIVO | MONOACYLGLYCEROL LIPASE | ALZHEIMERS-DISEASE | CEREBROSPINAL-FLUID | NEUROSCIENCES | FACTOR-ALPHA | INDUCED NEUROTOXICITY | HUNTINGTONS-DISEASE | UP-REGULATION | BRAIN | Neuroprotective Agents - therapeutic use | Tyrosine 3-Monooxygenase - metabolism | Motor Activity - drug effects | Male | Furans - therapeutic use | Brain - metabolism | Dose-Response Relationship, Drug | Time Factors | Benzodioxoles - therapeutic use | Cell Death - drug effects | Endocannabinoids - therapeutic use | Parkinson Disease - diet therapy | Disease Models, Animal | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology | Parkinson Disease - complications | Parkinson Disease - pathology | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Neurotoxins - toxicity | Brain - drug effects | Animals | Arachidonic Acids - therapeutic use | Piperidines - therapeutic use | Cyclooxygenase 2 - metabolism | Brain - pathology | Glycerides - therapeutic use | Gait Disorders, Neurologic - drug therapy | Mice | Gait Disorders, Neurologic - etiology | Parkinson Disease - etiology | Tremor | COX-2 inhibitors | CE, coefficient of error | ECS, endocannabinoid system | CB, cannabinoid | PPAR, peroxisome proliferator-activated receptor | TNF-α, tumor necrosis factor-alpha | MPP+, 1-methyl-4-phenylpyridinium | MAGL, monoacylglycerol lipase | CV, coefficient of variance | MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | HPLC, high-performance liquid chromatography | PD, Parkinson's disease | SNpc, substantia nigra pars compacta | IL, interleukin | TH, tyrosine hydroxylase | BOS, base of support | FAAH, fatty acid amide hydrolase | DOPAC, 3,4-dihydrophenylacetic acid | Research Paper | 2-AG, 2-arachidonoylglycerol | COX-2, cyclo-oxygenase-2
Journal Article
by Zhang, J and Hu, M and Teng, ZQ and Tang, YP and Chen, C
JOURNAL OF NEUROSCIENCE, ISSN 0270-6474, 11/2014, Volume 34, Issue 45, pp. 14919 - 14933
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 05/2018, Volume 15, Issue 1, pp. 142 - 15
Journal Article